Citation: E. Mccall et al., THE EFFECTS OF A NOVEL SODIUM (NA) CHANNEL ENHANCER ON CONTRACTION INCARDIAC MYOCYTES ISOLATED FROM A RAT MODEL OF HEART-FAILURE, The FASEB journal, 12(4), 1998, pp. 2377-2377
Citation: Mi. Steinberg et Sa. Wiest, POTENTIATION OF (3)[H]-2-BENZOFURANYL-2-IMIDAZOLINE (BFI) BINDING TO HUMAN PLATELETS BY THE MONOAMINE-OXIDASE INHIBITOR (MAOI), TRANYLCYPROMINE (TCP), The FASEB journal, 12(4), 1998, pp. 2587-2587
Authors:
TANIMURA M
SHEVLYAGIN S
SHIMOYAMA H
STEINBERG MI
BORZAK S
GOLDSTEIN S
SABBAH HN
Citation: M. Tanimura et al., LY366634, A NOVEL SODIUM-CHANNEL ACTIVATOR, IMPROVES LEFT-VENTRICULARFUNCTION IN DOGS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 8094-8094
Citation: Sa. Wiest et Mi. Steinberg, BINDING OF [H-3] 2-(2-BENZOFURANYL)-2-IMIDAZOLINE (BFI) TO HUMAN BRAIN - POTENTIATION BY TRANYLCYPROMINE, Life sciences, 60(9), 1997, pp. 605-615
Citation: E. Mccall et Mi. Steinberg, THE EFFECTS OF LY-368052 ON CONTRACTION IN ISOLATED CARDIAC MYOCYTES, Biophysical journal, 72(2), 1997, pp. 157-157
Citation: Sa. Wiest et Mi. Steinberg, BINDING OF H-3 2-BENZOFURANYL-2-IMIDAZOLINE (BFI), TO HUMAN BRAIN - POTENTIATION BY TRANYLCYPROMINE, The FASEB journal, 10(3), 1996, pp. 899-899
Citation: Rj. Sweeney et al., EFFECTS OF FLECAINIDE, ENCAINIDE, AND CLOFILIUM ON VENTRICULAR REFRACTORY PERIOD EXTENSION BY TRANSCARDIAC SHOCKS, PACE, 19(1), 1996, pp. 50-60
Citation: Mi. Steinberg, SECURITIES LITIGATION DEVELOPMENTS - THE BESPEAKS CAUTION DOCTRINE AND RELATED DEFENSES, Securities regulation law journal, 23(4), 1996, pp. 447-451
Authors:
PALKOWITZ AD
STEINBERG MI
ZIMMERMAN KM
THRASHER KJ
HAUSER KL
BOYD DB
Citation: Ad. Palkowitz et al., SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A NOVEL SERIES OF 5-ARYL BENZIMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(9), 1995, pp. 1015-1020
Citation: Zh. Zhang et Mi. Steinberg, LY-97241 ACCELERATES THE APPARENT RATE OF INACTIVATION OF TRANSIENT OUTWARD K- CHARACTERIZATION OF OPEN-CHANNEL BLOCK( CURRENT ), The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 249-257
Authors:
STEINBERG MI
PALKOWITZ AD
THRASHER KJ
REEL JK
ZIMMERMAN KM
WHITESITT CA
SIMON RL
HAUSER KL
LIFER SL
PFEIFER W
TAKEUCHI K
WIEST SA
VASUDEVAN V
BEMIS KG
DEETER JB
BARNETT CJ
WILSON TM
MARSHALL WS
BOYD DB
Citation: Mi. Steinberg et al., CHIRAL RECOGNITION OF THE ANGIOTENSIN-II (AT(1)) RECEPTOR BY A HIGHLYPOTENT PHENOXYPROLINE OCTANOAMIDE, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 51-56
Authors:
PALKOWITZ AD
STEINBERG MI
THRASHER KJ
REEL JK
HAUSER KL
ZIMMERMAN KM
WIEST SA
WHITESITT CA
SIMON RL
PFEIFER W
LIFER SL
BOYD DB
BARNETT CJ
WILSON TM
DEETER JB
TAKEUCHI K
RILEY RE
MILLER WD
MARSHALL WS
Citation: Ad. Palkowitz et al., STRUCTURAL EVOLUTION AND PHARMACOLOGY OF A NOVEL SERIES OF TRIACID ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(26), 1994, pp. 4508-4521
Citation: Mj. Kornel et al., SYNTHESIS OF P-AMINOBENZAMIDES OF AMINOPIPERIDAZINES AS POTENTIAL ANTIARRHYTHMIC AGENTS, Journal of heterocyclic chemistry, 31(4), 1994, pp. 967-971
Citation: Mi. Steinberg, CORPORATE-LAW SYMPOSIUM - THE EMERGENCE OF STATE SECURITIES-LAWS - PARTLY SUNNY SKIES FOR INVESTORS, University of Cincinnati law review, 62(2), 1993, pp. 395-428
Authors:
HOBERG TE
HOLDERMAN MV
KREIDER GP
LONG JC
SHIPMAN M
STEINBERG MI
Citation: Te. Hoberg et al., 1993 CORPORATE-LAW SYMPOSIUM - PRESENTATIONS AND PANEL DISCUSSION, University of Cincinnati law review, 62(2), 1993, pp. 533-572
Authors:
LIN HS
RAMPERSAUD AA
ZIMMERMAN K
STEINBERG MI
BOYD DB
Citation: Hs. Lin et al., SYNTHESIS AND INVITRO EVALUATION OF RBOXYL)-1-CYCLOALKEN-1-YL]PHENYL]METHYL]IMIDAZOLES AS NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of the Chinese Chemical Society, 40(3), 1993, pp. 273-282